ORIGINAL RESEARCH article
Front. Pharmacol., 24 January 2019
Sec. Experimental Pharmacology and Drug Discovery
Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.01558
RETRACTED: DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression
Yanchun Chen 1
Qiaozhen Wang 2
Qing Wang 2
Jinmeng Liu 1
Xin Jiang 1
Yawen Zhang 1
Yongxin Liu 3
Fenghua Zhou 4
Huancai Liu 5*
1. Department of Histology and Embryology, School of Clinical Medicine, Weifang Medical University, Weifang, China
2. Department of Human Anatomy, School of Clinical Medicine, Weifang Medical University, Weifang, China
3. Department of Anesthesiology, Weifang Medical University, Weifang, China
4. Department of Pathology, School of Clinical Medicine, Weifang Medical University, Weifang, China
5. Department of Joint Surgery, Affiliated Hospital, Weifang Medical University, Weifang, China
Summary
Citation
Chen Y, Wang Q, Wang Q, Liu J, Jiang X, Zhang Y, Liu Y, Zhou F and Liu H (2019) RETRACTED: DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression. Front. Pharmacol. 9:1558. doi: 10.3389/fphar.2018.01558
Received
08 November 2018
Accepted
21 December 2018
Published
24 January 2019
Volume
9 - 2018
Edited by
Dong-Hua Yang, St. John’s University, United States
Reviewed by
Bo Tian, National Tsing Hua University, Taiwan; Yue-Li Sun, Guangdong Provincial People’s Hospital, China
Updates
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.